For the Inventor, By the Inventor

Enter assignee name

Parkville, Australia

Ctxt Pty Limited

Calculating rank

USPTO Granted Patents = 18

EPO Patents = 17

Forward Citations = 14

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Michelle Ang Camerino (13 out of 16 patents)

Paul Anthony Stupple (11 out of 33 patents)

Scott Raymond Walker (9 out of 14 patents)

4. Benjamin Joseph Morrow (6 out of 8 patents)

5. Paul Anthony Stupple (6 out of 6 patents)

6. Richard Charles Foitzik (5 out of 12 patents)

7. Ylva Elisabet Bergman Bozikis (5 out of 5 patents)

8. Ylva Elisabet Bergman (4 out of 7 patents)

9. H Rachel Lagiakos (4 out of 5 patents)

10. Jonathan Grant Hubert (4 out of 4 patents)

11. Anthony Nicholas Cuzzupe (3 out of 3 patents)

12. Scott Channing Sutton (2 out of 15 patents)

13. Pei-Pei Kung (2 out of 16 patents)

14. John Feutrill (2 out of 3 patents)

15. Graeme Irvine Stevenson (2 out of 2 patents)

18 patents: Sort by Forward Citations

1. 12617780 - BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING (2026-05-05),

2. 12415785 - Compound modulators of sting (2025-09-16),

3. 12384801 - Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting (2025-08-12),

4. 12371425 - Benzisoxazole sulfonamide derivatives (2025-07-29),

5. 12365655 - Compounds (2025-07-22),

6. 11911372 - Compounds (2024-02-27),

7. 11613525 - Substituted condensed thiophenes as modulators of sting (2023-03-28),

8. 11492346 - Benzisoxazole sulfonamide derivatives (2022-11-08),

9. 11028101 - 3-oxa-8-azabicyclo[3.2.1]octane derivatives and their use in the treatment of cancer and hemoglobinopathies (2021-06-08),

10. 10961256 - PRMT5 inhibitors (2021-03-30),

11. 10787434 - Benzopiperdine derivatives and their use in the treatment of cancer and hemoglobinopathies (2020-09-29),

12. 10745380 - Pyridine derivatives and their use in the treatment of cancer and hemoglobinopathies (2020-08-18),

13. 10647708 - Tetrahydroisoquinoline derived PRMT5-inhibitors (2020-05-12),

14. 10550096 - Tetrahydroisoquinolines as PRMT5 inhibitors (2020-02-04),

15. 10519167 - 3-oxa-8-azabicyclo[3.2.1]octane derivatives and their use in the treatment of cancer and hemoglobinopathies (2019-12-31),

Company Overview

Ctxt Pty Limited is an innovative technology company based in Parkville, Australia, specializing in advanced software solutions. The organization focuses on developing cloud-based applications that enhance operational efficiency and data management for various industries. With a commitment to research and development, Ctxt leverages cutting-edge technologies to create tailored solutions that address complex business challenges, fostering growth and adaptability in a rapidly evolving digital landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

18 Patents

#6 in Parkville

#204 in Australia

#34,244 in the World

Parkville, Australia

Ctxt Pty Limited

Forward Citations = 14

23 inventors:

Michelle Ang Camerino (13 out of 16 patents)

Paul Anthony Stupple (11 out of 33 patents)

Scott Raymond Walker (9 out of 14 patents)

4. Benjamin Joseph Morrow (6 out of 8 patents)

5. Paul Anthony Stupple (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ctxt Pty Limited. Retrieved from https://idiyas.com/company/ctxt-pty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…